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558Endovascular aortic aneurysm repair surveillance
may not be necessary for the ﬁrst 3 years after an
initially normal duplex postoperative study
Douglas A. Troutman, DO, Mohammed Chaudry, MD, Matthew J. Dougherty, MD, and
Keith D. Calligaro, MD, Philadelphia, Pa
Objective: We have previously shown that duplex ultrasonography (DU) may replace computed tomography angiography
(CTA) as the primary surveillance tool for endovascular aortic aneurysm repair (EVAR). Current Society for Vascular
Surgery practice guidelines suggest that if CTA does not document endoleak, aneurysm sac enlargement, or limb stenosis
by 12 months after EVAR, surveillance studies may be performed annually. The purpose of this study was to determine
whether the time to the second surveillance DU study can be safely postponed to 3 years after EVAR if the initial study
ﬁnding is normal.
Methods: Between 1998 and 2013, DU surveillance was performed in our accredited noninvasive vascular laboratory at
1 week, 6 months, and annually after 410 EVARs (follow-up: mean, 35 months; range, 0.5-151 months). DU was used to
measure sac diameter, intrasac endoleak peak systolic velocities (PSVs), and PSVs within endograft limbs. If an endoleak,
limb stenosis, or increase in sac size was documented, DU surveillance was performed more frequently or CTA was
performed, followed by intervention if appropriate.
Results: On the basis of DU surveillance, 113 patients (28%) were diagnosed with either endoleak or graft limb stenosis
during the follow-up period. There were 95 patients (23%) with 118 endoleaks (15 [13%] type I, 90 [76%] type II, 11
[9%] type III, 2 [2%] type IV). There were 18 (4%) patients with limb stenosis deﬁned as PSV >300 cm/s. Intervention
was performed in 32 (28%) of the 113 patients with endoleak or limb stenosis, or in 8% of the total group (32 of 410),
during the follow-up period of 0.5 to 151 months. Only 2.2% of the patients (7 of 325) with an initially normal ﬁnding
on post-EVAR DU went on to develop endoleak or limb stenosis that required intervention during 3-year follow-up
compared with 25% of patients (21 of 85) with an initially abnormal ﬁnding on post-EVAR DU (P [ .0001).
Conclusions: These ﬁndings suggest that follow-up DU surveillance can be postponed until 3 years after EVAR if the
initial result of surveillance DU is normal (no endoleak, sac enlargement, stenosis), with minimal risk of an adverse clinical
event. (J Vasc Surg 2014;60:558-62.)The ﬁrst endovascular aortic aneurysm repair
(EVAR) was described in 1991.1 By 2013, approximately
75% of the reported 63,000 abdominal aortic aneurysms
(AAAs) were repaired by EVAR in the United States.2
Registry data suggest that 13% to 22% of EVARs will
need reintervention.3,4 Therefore, it has been recom-
mended that all EVARs need lifetime surveillance.5,6
Surveillance protocols can add signiﬁcant ﬁnancial burden
and patient inconvenience after the initial procedure. There-
fore, it would be beneﬁcial to identify a subset of post-EVAR
patients who could be monitored less often. Likewise, a
subset of patients may need more frequent monitoring if
they are at a higher risk to require reintervention.the Section of Vascular Surgery, Pennsylvania Hospital.
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guidelines suggest that if the initial surveillance study
does not document endoleak, aneurysm sac enlargement,
or limb stenosis at 1 and 12 months after EVAR, surveil-
lance studies may be performed annually thereafter.5 The
purpose of this study was to determine whether the time
interval until the second surveillance duplex ultrasonogra-
phy (DU) study can be safely postponed to 3 years after
EVAR if the initial study ﬁnding is normal.
METHODS
Between 1998 and 2013, 410 patients who underwent
EVAR by the vascular surgery service at Pennsylvania Hos-
pital were observed by evolving DU surveillance protocols.
DU surveillance after EVAR was performed in our Interso-
cietal Committee of Accredited Vascular Laboratory-
accredited noninvasive vascular laboratory. Before 2004,
our protocol consisted of computed tomography angiog-
raphy (CTA) and DU within 2 weeks of discharge, at 6
and 12 months, and then annually after EVAR. From
2004 to 2009, CTA and DU were ordered within 2 weeks
of discharge, then DU alone was used for surveillance at
6 and 12 months, then annually after EVAR.7,8 Since
2009, we have used DU alone for surveillance obtained
at 1 week after EVAR, then at 6 and 12 months, then
annually after EVAR if no abnormalities were detected.
Table I. Types of endoleaks and graft limb stenoses
detected by duplex ultrasonography (DU)
DU surveillance after EVAR
(mean, 35 months; range, 0.5-151 months)
Endoleaks detected
Graft limb
stenosis
Abnormalities
detected
Type I 15 (13%) 18
Type II 90 (76%)
Type III 11 (9%)
Type IV 2 (2%)
Total 118 in 95 patients 18 in 18 patients 113 of 410 (28%)
EVAR, Endovascular aortic aneurysm repair.
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tolic velocities (PSVs), and PSVs within the endograft limbs.
We have shown that CTA and DU measurements of aneu-
rysm sac diameter after EVAR were equivalent.7 Limb steno-
sis was deﬁned as PSVs >300 cm/s within the endograft
limbs.9 If endoleak or limb stenosis was detected, DU sur-
veillance was performed more frequently, CTA was ob-
tained, or direct endovascular intervention was performed.
If sac diameter increased by 0.5 cm, CTA was obtained.
There was a high correlation of endoleaks seen in our nonin-
vasive vascular laboratory’s DU compared with CTA.7
DU was performed with the patient in the supine posi-
tion after fasting overnight. Imaging of the aorta was per-
formed from the celiac artery to the femoral arteries in
the longitudinal and transverse axes. Measurements of
the aorta were made in the transverse axis at the level of
the celiac artery, at the level of the renal arteries, at the
maximal aneurysm diameter, and just proximal to the aortic
bifurcation. The entire aorta was scanned for any evidence
of endoleaks. B-mode imaging and spectral Doppler were
used to record any endoleaks. PSVs were recorded
throughout the endograft and adjacent attachment sites
with B-mode imaging and spectral Doppler.
DU scans after EVAR were performed by experienced
vascular laboratory technologists. Our DU was equipped
with 10.4 software (Philips HD-11, Philips DHI-5000,
Philips HDI-3000; Philips, Bothell, Wash). All patients
were prospectively maintained in our computer registry
(Access; Microsoft Corp, Redmond, Calif). Statistical anal-
ysis was performed with a Fisher exact test, with P values
< .05 considered statistically signiﬁcant.
RESULTS
From September 1998 to June 2013, there were 410
patients who underwent EVAR at Pennsylvania Hospital
by the vascular surgery service and were observed with
postoperative DU surveillance (mean, 35 months; range,
0.5-151 months). There were 56 Ancure (Endovascular
Technologies, Menlo Park, Calif), 139 AneuRx (Medtronic,
Minneapolis, Minn), 8 Talent (Medtronic), 39 Endurant
(Medtronic), 61 Excluder (WL Gore and Associates, Flag-
staff, Ariz), 78 Zenith (Cook Medical Inc, Bloomington,
Ind), and 29 Powerlink (Endologix, Irvine, Calif) grafts
used during this 15-year period. The average age of this
cohort was 73 years (range, 54-91 years), and 77% were
men. The average diameter of AAA repaired was 5.8 cm
(range, 4.4-9.8 cm).
On the basis of DU surveillance, 113 (28%) patients
were diagnosed as having an endoleak (95 patients [23%]
with 118 endoleaks: 15 [13%] type I, 90 [76%] type II,
11 [9%] type III, 2 [2%] type IV) or graft limb stenosis
(18 patients [4%], based on PSV >300 cm/s) during the
follow-up period (Table I). Intervention was performed
in 32 (28%) of the 113 patients with endoleak or limb
stenosis, or in 8% of the total group (32 of 410), during
the follow-up period of 0.5 to 151 months. Only 2.2% of
patients (7 of 325) with an initially normal ﬁnding on
post-EVARDUwent on to develop endoleak, limb stenosis,or kinking that required intervention during 3-year
follow-up compared with 25% of patients (21 of 85)
with an initially abnormal ﬁnding on post-EVAR DU
(P ¼ .0001) (Table II).
Of the 95 patients diagnosed with endoleaks, 20% of pa-
tients (19 of 95) had intervention for 30 endoleaks. These
interventions included nine repairs for type I endoleaks,
14 repairs for type II endoleaks, ﬁve repairs for type III
endoleaks, and two repairs for type IV endoleaks. There
was no correlation with the type of endograft used and
type of endoleak detected. Proximal endovascular cuffs, Pal-
maz stents, and distal limb extensions were used to repair
type I endoleaks. Type II endoleaks were intervened on if
they were thought to have caused a sac growth rate of
0.5 cm or more. Two patients with type II endoleaks had
open surgery with oversewing of lumbar vessels. All other
type II endoleaks were treated with selective angiography
and coil embolizations or translumbar embolizations/poly-
merization. Type III and type IV endoleaks were treated
with relining of the endograft. The average time to reinter-
vention for all 19 patients with endoleaks was 38 months
(range, 6-96 months). Nine of these patients had an initially
abnormal ﬁnding on DU surveillance, with the average time
to reintervention being 35 months (range, 6-64 months).
Of the 10 patients who had an initially normal ﬁnding on
DU surveillance, the average time to reintervention was
41 months (range, 8-96 months).
Seven of the 10 patients with initially normal ﬁndings
on DU surveillance who underwent reintervention did so
within 3 years. In this subset, there were two type I endo-
leaks, four type II endoleaks, and one limb stenosis. All pa-
tients had successful endovascular treatment. The mean
time to reintervention in this subset of patients was
21 months (range, 8-36 months) (Table III).
Of the 18 patients who had limb stenosis on the basis
of the preceding criteria, 13 underwent endovascular or
open surgical treatment (all with initially abnormal ﬁndings
on DU). Six of these patients had reintervention to main-
tain patency. Seven patients had reintervention for limb
thrombosis. Open surgery was performed in three patients,
including femorofemoral bypass (two) and axillofemoral
bypass (one). The remaining 10 patients had endovascular
reintervention that included catheter-directed thrombolysis
Table II. Rates of intervention after endovascular aortic aneurysm repair (EVAR)
Post-EVAR
Totals
Interventions on patients with
initially abnormal ﬁndings on DU
Interventions on patients with
initially normal ﬁndings on DU
# At 3 years At 2 years At 3 years At 4 years
Abnormal ﬁndings on DU with
interventions
28% (32/113)
Initially abnormal ﬁndings on DU 21% (85/410) 25% (21/85)
Initially normal ﬁndings on DU 79% (325/410) 2.2% (7/325)
Total cohort 8% (32/410) 5.1% (21/410) 1.0% (4/410) 1.7% (7/410) 1.7% (7/410)
DU, Duplex ultrasonography.
Table III. Interventions on patients with initially normal
ﬁndings on duplex ultrasonography (DU)
Patient
Type of
endoleak
Limb
stenosis
Time of
intervention,
months Type of intervention
1 Type I 8 Palmaz stent
2 Type II 12 Translumbar
embolization
3 Type II 13 Translumbar
embolization
4 Type II 24 Selective
angiography, coil
embolization
5 Type I 29 Proximal cuff
6 Right limb 36 Balloon angioplasty
and stent
7 Type II 36 Selective
angiography, coil
embolization
8 Type III 68 Relining of endograft
limb
9 Type I 84 Extension of distal
limb, coil
embolization of
hypogastric artery
10 Type II 96 Translumbar
embolization
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plasty with or without stent, or stent graft. There was no
correlation between the type of endograft used and rate
of limb stenosis. The average time to intervention for
limb stenosis was 43 months (range, 1-120 months).
Therefore, we would have missed 1.0% (4 of 410),
1.7% (7 of 410), and 1.7% (7 of 410) at 2-, 3- and
4-year follow-up, respectively, of all patients who would
have potentially beneﬁted from useful reintervention for
an endoleak or limb stenosis if follow-up surveillance DU
was postponed.
DISCUSSION
The treatment algorithm for AAAs has dramatically
shifted during the past decade. In 2013, approximately75% of all AAAs were repaired with EVAR in the United
States.2 Surveillance after open surgical repair has not
been considered necessary because the AAA was deﬁni-
tively excluded. However, occasional patients may develop
anastomotic or other aneurysms that are not detected on
physical examination.10 Therefore, current Society for
Vascular Surgery guidelines recommend CT surveillance
every 5 years after open surgical repair.5
The need for long-term surveillance after endovascular
repair is more widely appreciated. Patients undergoing
EVAR for AAA remain at small but persistent risk for aneu-
rysm rupture. The EUROSTAR (European Collaborators
on Stent/graft Techniques for aortic Aneurysm Repair)
and OVER (Open vs Endovascular Repair) registries found
an annual rate of AAA rupture of 0.7% to 1.4% after
EVAR.3,11 Therefore, it has been recommended that
post-EVAR patients undergo lifelong surveillance.5
The optimal type and frequency of post-EVAR surveil-
lance remain undeﬁned. Others have recommended that
CTA be used as the primary imaging modality because it
may be more speciﬁc at identifying abnormalities such as
endoleak, sac expansion, limb stenosis, and kinking after
EVAR. However, we have shown the DU and CTA are
equivalent in determining sac size as well as in detecting
endoleaks.7 We have also shown that DU is effective in
detecting limb stenosis or kinking after EVAR.9 Therefore,
we believe that DU is as efﬁcacious as CTA for post-EVAR
surveillance.
DU has advantages compared with CTA. Our technol-
ogists can visualize physiologic as well as anatomic abnor-
malities, whereas CTA can detect only anatomic
abnormalities. DU is also more cost-effective than CTA.
Bendick et al12 reported a cost savings of more than
$16,000 per patient if a DU surveillance protocol was
used compared with a CTA protocol during a 3-year
period. Our group has also reported a cost savings beneﬁt
of approximately $1600 per patient per year with use of a
primarily DU-only surveillance protocol.7 In addition,
DU does not require repeated radiation exposure that
could potentially increase the risk of cancer as well as the
risk of acute kidney injury due to contrast-induced
nephropathy.13
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occurs or for type II endoleak with >0.5 cm aneurysm
sac expansion. CTA may sometimes be helpful in planning
intervention for graft limb stenosis in some cases.7-9
Currently, the timing for post-EVAR surveillance is
recommended at 1 and 12 months, then annually if no ab-
normalities are detected. If abnormalities are detected, it is
recommended that the imaging interval be shortened to
every 6 months.5 We agree that an initial scan, preferably
DU, should be done to establish a post-EVAR baseline.
The initial DU study is performed in our ofﬁce during
the patient’s ﬁrst postoperative visit so that he or she
does not have to return for another visit at 1 month. Our
results suggest that if the initial scan does not show any ab-
normalities (ie, endoleak, limb stenosis), the interval until
the second surveillance DU study may be safely postponed
to 3 years after EVAR. Our data support this recommenda-
tion by showing that only 2.2% of patients who had normal
ﬁndings on DU initially after EVAR later required reinter-
vention. This is in stark contrast to a 25% reintervention
rate after 3-year follow-up if the initial DU detected an
abnormality. Patients who are treated outside of an endog-
raft’s instructions for use, even if their initial DU ﬁnding
was normal, should most likely have surveillance annually
1 year after EVAR.
The mean time to reintervention was 41 months in the
subset of patients with initially normal ﬁndings on DU.
However, there were seven patients in this group who
had re-intervention within 36 months, or 3 years, of
EVAR. Although the rate of intervention after a DU scan
with initially normal ﬁndings was only 2.2%, some clinicians
might question if this is an acceptably low rate to omit sur-
veillance until 3 years postoperatively. The potential
adverse effects of omitting surveillance for 3 years after an
initial normal study result after EVAR should be weighed
against the costs and adverse effects of frequent CT scans
or DU studies. DU surveillance after 3 years should most
likely return to yearly surveillance because we do not
have long-term data to support longer surveillance
intervals.
Other groups have also suggested alternatives to cur-
rent Society for Vascular Surgery recommended surveil-
lance guidelines if the ﬁrst post-EVAR surveillance study
result is normal. Kirkpatrick14 has recommended that if
the 1-month post-EVAR CTA does not demonstrate an
endoleak, less frequent CTA surveillance is needed. Stern-
bergh15 noted that if the initial post-EVAR surveillance
CTA does not demonstrate any abnormalities, the rate of
freedom from reintervention at 5 years may be up to
85%. We aggressively pursued DU abnormalities during
the 3 years after EVAR, and the incidence of reintervention
would likely have been much less in our series had we not
prophylactically intervened.
There are some limitations to this study. First, this
study is a retrospective review of a prospectively maintained
database during the past 15 years. Second, the average
follow-up of the study was 35 months. Last, DU-only
surveillance after EVAR is highly dependent on the vascularlaboratory technologists. The accuracy of the DU examina-
tion can be time-consuming and dependent on the skill of
the technologists; therefore, DU results will certainly vary
between noninvasive vascular laboratories.
CONCLUSIONS
These ﬁndings show that post-EVAR patients with an
initially normal DU surveillance study result are at signiﬁ-
cantly lower risk for reintervention than are patients with
initially abnormal study results. We would suggest that sur-
veillance DU studies may be postponed until 3 years after
EVAR if the initial result of surveillance DU is normal
(no endoleak, sac enlargement, or limb stenosis) with min-
imal risk of an adverse clinical event.AUTHOR CONTRIBUTIONS
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